verapamil has been researched along with Arrhythmogenic Right Ventricular Dysplasia in 3 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Arrhythmogenic Right Ventricular Dysplasia: A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the 12 patients with structural heart disease (including two with arrhythmogenic right ventricular dysplasia), adenosine (260 to 550 microg/kg) failed to slow or terminate VT." | 3.70 | Catecholamine facilitated reentrant ventricular tachycardia: uncoupling of adenosine's antiadrenergic effects. ( Lerman, BB; Markowitz, SM; Mittal, S; Slotwiner, D; Stein, KM, 1999) |
| "Outflow tract ventricular tachycardia (VT) is the most common form of idiopathic VT in clinical practice." | 2.46 | [Idiopathic ventricular tachycardia: clinical characteristics and management]. ( Agricola, P; Donato, G; Durin, O; Inama, G; Pedrinazzi, C; Romagnoli, G, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Durin, O | 1 |
| Pedrinazzi, C | 1 |
| Agricola, P | 1 |
| Romagnoli, G | 1 |
| Donato, G | 1 |
| Inama, G | 1 |
| Erkapic, D | 1 |
| Neumann, T | 1 |
| Schmitt, J | 1 |
| Sperzel, J | 1 |
| Berkowitsch, A | 1 |
| Kuniss, M | 1 |
| Hamm, CW | 1 |
| Pitschner, HF | 1 |
| Lerman, BB | 1 |
| Stein, KM | 1 |
| Markowitz, SM | 1 |
| Mittal, S | 1 |
| Slotwiner, D | 1 |
1 review available for verapamil and Arrhythmogenic Right Ventricular Dysplasia
| Article | Year |
|---|---|
[Idiopathic ventricular tachycardia: clinical characteristics and management].
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Calcium Channe | 2010 |
2 other studies available for verapamil and Arrhythmogenic Right Ventricular Dysplasia
| Article | Year |
|---|---|
Electrical storm in a patient with arrhythmogenic right ventricular cardiomyopathy and SCN5A mutation.
Topics: Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Electrocardiography; Humans; Mal | 2008 |
Catecholamine facilitated reentrant ventricular tachycardia: uncoupling of adenosine's antiadrenergic effects.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular | 1999 |